The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says 'The biggest investment risk is not the volatility of prices, but whether you will ...

Cellink AB (publ) (STO:CLNK B) shareholders might be concerned after seeing the share price drop 14% in the last quarter. But looking back over the last year, the returns have actually been rather ...

BLACKSBURG — A lab inside the Virginia Tech Corporate Research Center turned green under the lights of one of Cellink’s 3-D printers on a recent afternoon, a signal that the company’s latest nose was ...

The recent breakthrough in harvesting pig organs for mammalian heart transplants has put the spotlight back on the efforts of many researchers around the world to help solve the world’s organ shortage ...

A strategic agreement has been announced that will see all shares of Cytena be sold to Cellink for a purchase price of EUR30.25 million (US$33.79 million). A strategic agreement has been announced ...

Cellink focuses on the development and commercialization of bioprinting technologies that allow researchers to 3D print human organs and tissues for the development of pharmaceutical and cosmetic ...

With today’s 3D bioprinters, two separate extruders are typically used; one for laying down a “bioink” and another for laying down the cells onto that ink. With CELLINK, the cells and the bioink may ...

One day we’ll replace our old knackered organs with brand new ones that are printed out exclusively for us with a 3D printer. And when we do, we’ll quite possibly use a printer like the Cellink Bio X ...

CELLINK today announced its partnership with Made In Space, Inc. (MIS), the industry leader for space manufacturing technologies, to develop advanced bioprinting technology for space. The partnership ...

Cellink’s BIO X6, a six-printhead bioprinting platform, offers the capability to combine more materials, cells, and tools to enhance research applications across the bioprinting field. BIO X6, a ...

CELLINK has been granted a patent for a unique cellulose-based bioink technology enabling bioprinting of multiple cell types for cell culturing, tissue engineering and regenerative medicine ...